A detailed history of Rosenberg Matthew Hamilton transactions in Becton Dickinson & CO stock. As of the latest transaction made, Rosenberg Matthew Hamilton holds 185 shares of BDX stock, worth $41,486. This represents 0.01% of its overall portfolio holdings.

Number of Shares
185
Previous 221 16.29%
Holding current value
$41,486
Previous $51,000 13.73%
% of portfolio
0.01%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$221.47 - $242.41 $7,972 - $8,726
-36 Reduced 16.29%
185 $44,000
Q1 2024

Apr 19, 2024

BUY
$233.45 - $247.73 $13,540 - $14,368
58 Added 35.58%
221 $54,000
Q4 2023

Jan 12, 2024

BUY
$232.24 - $267.23 $8,592 - $9,887
37 Added 29.37%
163 $39,000
Q1 2022

Apr 14, 2022

BUY
$243.64 - $270.48 $11,694 - $12,983
48 Added 61.54%
126 $34,000
Q3 2021

Oct 12, 2021

BUY
$232.72 - $256.47 $7,447 - $8,207
32 Added 69.57%
78 $19,000
Q2 2020

Aug 04, 2020

BUY
$219.9 - $263.41 $10,115 - $12,116
46 New
46 $11,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Rosenberg Matthew Hamilton Portfolio

Follow Rosenberg Matthew Hamilton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rosenberg Matthew Hamilton, based on Form 13F filings with the SEC.

News

Stay updated on Rosenberg Matthew Hamilton with notifications on news.